205 related articles for article (PubMed ID: 21899971)
1. Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis.
Lu YY; Chen JH; Liang JA; Wang HY; Lin CC; Lin WY; Kao CH
Eur J Radiol; 2012 Sep; 81(9):2411-6. PubMed ID: 21899971
[TBL] [Abstract][Full Text] [Related]
2. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
3. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
Soubra A; Hayward D; Dahm P; Goldfarb R; Froehlich J; Jha G; Konety BR
World J Urol; 2016 Sep; 34(9):1229-37. PubMed ID: 26847182
[TBL] [Abstract][Full Text] [Related]
5. Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.
Goodfellow H; Viney Z; Hughes P; Rankin S; Rottenberg G; Hughes S; Evison F; Dasgupta P; O'Brien T; Khan MS
BJU Int; 2014 Sep; 114(3):389-95. PubMed ID: 24341486
[TBL] [Abstract][Full Text] [Related]
6. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
7. FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis.
Lu YY; Chen JH; Lin WY; Liang JA; Wang HY; Tsai SC; Kao CH
Clin Nucl Med; 2012 Sep; 37(9):833-7. PubMed ID: 22889770
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.
Zhang H; Xing W; Kang Q; Chen C; Wang L; Lu J
Tumour Biol; 2015 May; 36(5):3209-14. PubMed ID: 25809703
[TBL] [Abstract][Full Text] [Related]
9. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
Jeong IG; Hong S; You D; Hong JH; Ahn H; Kim CS
Ann Surg Oncol; 2015 Sep; 22(9):3150-6. PubMed ID: 25634779
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
14. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
Nayak B; Dogra PN; Naswa N; Kumar R
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Lin CY; Chen JH; Liang JA; Lin CC; Jeng LB; Kao CH
Eur J Radiol; 2012 Sep; 81(9):2417-22. PubMed ID: 21899970
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Sheikhbahaei S; Taghipour M; Ahmad R; Fakhry C; Kiess AP; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2015 Sep; 205(3):629-39. PubMed ID: 26295652
[TBL] [Abstract][Full Text] [Related]
18. Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.
Li Y; Yang ZQ; Ye H; Qi L; Hu JW
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):234-237. PubMed ID: 23592136
[TBL] [Abstract][Full Text] [Related]
19. Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
Tsai SC; Ou YC; Cheng CL; Li JR; Lin YC; Ho HC; Chiu KY; Su CK; Lin WY
Nuklearmedizin; 2015; 54(1):36-42. PubMed ID: 25345433
[TBL] [Abstract][Full Text] [Related]
20. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
Huang X; Yang J; Li J; Xiong Y
Medicine (Baltimore); 2020 Aug; 99(35):e20932. PubMed ID: 32871859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]